
In 2023, QualityMetric (QM) became an IQVIA business. This further enabled us to provide clinical outcome assessment (COA) licensing in addition to leveraging our combined innovative technology solutions and scientific expertise. Since our full integration into IQVIA will soon be complete, it is time to retire the QM brand.
As we remain committed to our same quality licensing and services, we invite you to find the legacy QM COAs you know, in addition to the other 160+ COA offerings on IQVIA's COA Marketplace.

QualityMetric is sharing new insights surrounding its SF-6Dv2 Health Utility Survey at an upcoming conference hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
On Tuesday, November 8th, at ISPOR Europe 2022 in Vienna, Austria, QM statistician Regina Rendas-Baum will offer insight on the development of the SF-6Dv2, a unique patient-reported outcomes (PRO) instrument used by many professionals in the clinical research space to capture health utility and inform product lifecycles. Data presented is obtained with support from QM’s science team, which includes Senior Scientist and Associate Director of Quantitative Research Kristen McCausland, PhD, MPH, and Chief Science Officer Jakob Bjorner, MD, PhD.
Don’t miss the informative session for both in-person and virtual event attendees.
In-Person and Virtual Poster Session 3
Acceptance Code HTA163
Presented by Regina Rendas-Baum, Statistician
Tuesday, November 8th, 2022
10:00–13:15 CET
View the full poster session abstract.
The International Society for Pharmacoeconomics and Outcomes Research is the leading professional society for health economics and outcomes research (HEOR) dedicated to improving global health decision-making. This year’s Europe conference takes place November 6–9, 2022, virtually and in person at the Austria Center Vienna.